Helsinn Reaps Benefits of Cytotoxic Molecule Demand

16.01.2014 - Strong Start - After beginning its investment in a brand-new cytotoxic molecule facility in Biasca, Switzerland, in 2011, Helsinn started production in July 2012. Now one and a...